Healthcare Sector
33 tracked companies with the latest linked quarter views, company pages, and peer coverage.
Companies in this sector
| Company | Latest quarter | Revenue | Sentiment |
|---|
| Sunpharma | Q3 FY26 | ₹15,469 Cr |
bullish
high
|
| Cipla | Q4 FY26 | ₹6,541 Cr |
bullish
high
|
| Apollo Hospitals Enterprise | Q3 FY26 | ₹6,477 Cr |
bullish
high
|
| Apollo Hospitals Enterprise | Q3 FY26 | ₹6,477 Cr |
bullish
high
|
| Torrent Pharmaceuticals | Q3 FY26 | ₹3,333 Cr |
bullish
high
|
| Piramal Pharma | Q4 FY26 | ₹2,752 Cr |
neutral
medium
|
| Emcure Pharmaceuticals | Q4 FY26 | ₹2,470 Cr |
bullish
high
|
| Fortis Healthcare | Q3 FY26 | ₹2,265 Cr |
bullish
high
|
| Raymond Lifestyle | Q4 FY26 | ₹1,776 Cr |
bullish
high
|
| Entero Healthcare Solutions | Q3 FY26 | ₹1,707 Cr |
bullish
high
|
| Ajanta Pharma | Q4 FY26 | ₹1,422 Cr |
bullish
high
|
| Akums Drugs | Q4 FY26 | ₹1,158 Cr |
bullish
high
|
| J B Chemicals | Q4 FY26 | ₹904 Cr |
neutral
medium
|
| Eris Lifesciences | Q3 FY26 | ₹807 Cr |
bullish
high
|
| Ventive Hospitality | Q4 FY26 | ₹779 Cr |
bullish
high
|
| Mahindra Lifespace Developers | Q4 FY26 | ₹670 Cr |
bullish
medium
|
| Westlife Foodworld | Q4 FY26 | ₹660 Cr |
bullish
medium
|
| Cohance Lifesciences | Q4 FY26 | ₹619 Cr |
bearish
high
|
| Aditya Birla Sun | Q4 FY26 | ₹458 Cr |
neutral
medium
|
| Onesource Specialty Pharma | Q4 FY26 | ₹428 Cr |
bullish
high
|
| Metropolis Healthcare | Q4 FY26 | ₹425 Cr |
bullish
high
|
| Artemis Medicare Services | Q4 FY26 | ₹279 Cr |
bullish
high
|
| Medi Assist Healthcare | Q4 FY26 | ₹242 Cr |
bullish
high
|
| Advanced Enzyme Technologies | Q4 FY26 | ₹203 Cr |
bullish
high
|
| Sat Kartar Life | Q4 FY26 | ₹200 Cr |
bullish
high
|
| Blue Jet Healthcare | Q3 FY26 | ₹192 Cr |
neutral
medium
|
| RPG Life Sciences | Q4 FY26 | ₹177 Cr |
bullish
high
|
| Senores Pharmaceuticals | Q4 FY26 | ₹175 Cr |
bullish
high
|
| Lincoln Pharmaceuticals | Q3 FY26 | ₹166 Cr |
bullish
medium
|
| Stanley Lifestyles | Q3 FY26 | ₹104 Cr |
bearish
medium
|
| Chandan Healthcare | Q3 FY26 | ₹65 Cr |
bullish
high
|
| Jagsonpal Pharmaceuticals | Q4 FY26 | ₹64 Cr |
bullish
high
|
| Anlon Healthcare | Q3 FY26 | ₹36 Cr |
bullish
high
|
